Workshop Agenda
SEEK ID: https://fairdomhub.org/documents/4183?version=2
Filename:
OneHealthdrugs_Agenda_WG1WG2_15052023_updated.pdf
Format: PDF document
Size: 289 KB
Export PNG
Creators and Submitter
Views: 972 Downloads: 89
Created: 10th May 2023 at 10:01
Last updated: 15th May 2023 at 11:32
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 2 (latest) Created 15th May 2023 at 11:32 by Ulrike Wittig
No revision comments
Version 1 (earliest) Created 10th May 2023 at 10:01 by Ulrike Wittig
No revision comments
Related items
Projects: de.NBI-SysBio, Kinetics on the move - Workshop 2016, Example use cases, SBEpo - Systems Biology of Erythropoietin, FAIRDOM & LiSyM & de.NBI Data Structuring Training, FAIRDOM, EnzymeML, GMDS Project Group "FAIRe Dateninfrastrukturen für die Biomedizinische Informatik", FAIRDOM Community Workers, MIX-UP, COVID-19 Disease Map, ERNEST Mapping Group Pilot Study, NMTrypI - New Medicines for Trypanosomatidic Infections, Standardization of enzyme-catalyzed reaction measurement, Standardization of enzyme-catalyzed reaction modelling, ModeleXchange initiative, CoVIDD - Coronavirus interactions in drug discovery - optimization and implementation, Mass spectrometry proteomics for biomarker discovery, Thymidylate synthase dimer dissociation, WG1 - Compound libraries coordination and integration of compound design, WG2 - Integration of early phase studies and low environmental impact actions, WG3 - Coordination of in vitro-to-in vivo translation of OneHealth leads and candidates, WG4 - Integration of R&D process-environmental studies and translation in informed whitepaper, WG5 - Promote dissemination, WG6 - Promote the transfer of knowledge, SABIO-VIS, SDBV/HITS, BioTarget Database, Compound Data
Institutions: Heidelberg Institute for Theoretical Studies
https://orcid.org/0000-0002-9077-5664
The recent COVID19 pandemic infection has undisclosed long-standing issues in the translation of drugs from animals to humans or vice-versa. Nearly 75% of emerging human infections worldwide originated from animals; existing drugs for human and animal (H&A) vector-borne diseases (VBD) are scarce, with limited efficacy, toxicity, and finite resources. Emerging environmental problems in pharmaceutical use/manufacturing increase attention in the field. The two drug pipelines are developed ...
Projects: WG1 - Compound libraries coordination and integration of compound design, WG2 - Integration of early phase studies and low environmental impact actions, WG3 - Coordination of in vitro-to-in vivo translation of OneHealth leads and candidates, WG4 - Integration of R&D process-environmental studies and translation in informed whitepaper, WG5 - Promote dissemination, WG6 - Promote the transfer of knowledge, BioTarget Database, Compound Data
Web page: https://onehealthdrugs.com/
Public web page: Not specified
Public web page: Not specified
The workshop “Novel leads and drugs and their mechanism of action in the field of vector borne parasitic disease” is jointly organized by WG1 “Compound libraries coordination and integration of compound design” and WG2 “Integration of early phase studies and low environmental impact actions” of the COST Action CA21111 OneHealthDrugs. The focus of the workshop is to bring together experts to report and discuss common definitions of novel leads and drugs and their mechanisms of action in view also ...
Start Date: 15th May 2023 (15th May 2023 (Europe/Berlin))
End Date: 15th May 2023 (15th May 2023 (Europe/Berlin))
Event Website: Not specified
Country: Not specified
City: online
